Abuse Potential Assessment of Cebranopadol, a Novel Dual Nociceptin (NOP) and Mu Opioid (MOP) Receptor (NMR) Agonist: Implications for Scheduling

cebranopadol (TRN-228) - Tris Pharma

morphine sulphate - Generic mfg.

hydromorphone hydrochloride - Generic mfg.

Megan Shram; Glen Apseloff; Joseph Grieco; David Fam; Marc Lesnick; James Hackworth

Jun 9, 2025